RemeGen Co., Ltd. (SHA:688331)
China · Delayed Price · Currency is CNY 89.28
-0.80 (-0.89%)
Nov 17, 2025, 2:14 PM CST
RemeGen Market Cap
RemeGen has a market cap or net worth of 47.65 billion as of November 14, 2025. Its market cap has increased by 266.91% in one year.
Market Cap
47.65B
Enterprise Value
48.66B
Revenue
2.23B
Ranking
n/a
PE Ratio
n/a
Stock Price
89.28
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 28.53B to 47.65B, an increase of 67.06%. That is a compound annual growth rate of 10.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 47.65B | 262.12% |
| Dec 31, 2024 | 13.16B | -53.43% |
| Dec 29, 2023 | 28.26B | -23.48% |
| Dec 30, 2022 | 36.93B | 18.81% |
| Dec 31, 2021 | 31.09B | -20.67% |
| Dec 31, 2020 | 39.18B | 37.36% |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 421.78B |
| WuXi AppTec | 285.68B |
| Shenzhen Mindray Bio-Medical Electronics | 251.81B |
| Sichuan Biokin Pharmaceutical | 153.59B |
| Aier Eye Hospital Group | 114.43B |
| Shanghai United Imaging Healthcare | 113.18B |
| Zhangzhou Pientzehuang Pharmaceutical., | 109.70B |
| Yunnan Baiyao Group Co.,Ltd | 101.81B |